Picture of 3i logo

III 3i News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsBalancedLarge CapNeutral

REG - 3i Group PLC - Director/PDMR Shareholding

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230608:nRSH1528Ca&default-theme=true

RNS Number : 1528C  3i Group PLC  08 June 2023

Market Abuse Regulation

 

MAR Article 19

 

On 8 June 2023, 3i Group plc (the "Company") was notified of the following.

 

On 7 June 2023 the persons discharging material responsibilities ("PDMRs")
named in the table below acquired for nil cost ordinary shares of 73 19/22p
each (ISIN: GB00B1YW4409) in the Company ("Shares") on the release of share
awards under the 3i Special Share Award Plan. On that date the Shares shown in
the column headed "Shares acquired" ceased to be subject to restrictions under
the Plan. The Shares (if any) shown in the column headed "Shares sold" were
sold on the same date at a price of £19.979 per share.

 

 PDMR          Shares acquired  Shares sold
 S Moseley     52,611           24,782
 B Sottomayor  52,611           24,782

 

On 7 June 2023 share awards under 3i Group Discretionary Share Plan (the
"Plan") held by the persons discharging managerial responsibilities ("PDMRs")
named in the table below vested.  On that date the Shares shown in the column
headed "Shares acquired" ceased to be subject to restrictions under the
Plan.  The Shares (if any) shown in the column headed "Shares sold" were sold
on the same date at a price of £19.979 per share.

 

 PDMR        Shares acquired  Shares sold
 K J Dunn    24,052           24,052
 J H Halai   11,272           5,314
 J Hatchley  16,760           0
 J Marie     10,630           5,012

 

The place of these transactions was the London Stock Exchange.

 

Ends

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHUPURCQUPWGWR

Recent news on 3i

See all news